<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000321388"><TermName>soblidotin</TermName><TermPronunciation>(soh-blih-DOH-tin)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of cancer. It is a type of tubulin inhibitor. Also called TZT-1027.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000731824" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;soblidotin&quot;" language="en" id="_3"/><MediaLink ref="CDR0000731825" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;soblidotina&quot;" language="es" id="_4"/><SpanishTermName>soblidotina</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento del cáncer. Es un tipo de inhibidor de la tubulina. También se llama TZT-1027.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-07-26</DateFirstPublished><DateLastModified>2008-11-21</DateLastModified></GlossaryTerm>
